These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4104719)

  • 1. Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.
    Bailey CC; Geary CG; Israëls MC; Whittaker JA; Brown MJ; Weatherall DJ
    Lancet; 1971 Jun; 1(7712):1268-71. PubMed ID: 4104719
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytarabine.
    Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute myeloid leukemia of adults with cytosine arabinoside in combination with 6-mercaptopurine.
    Buchanan JG; Matthews JR; Davison JG; Grigor RR; Casey TP
    Cancer; 1973 Oct; 32(4):789-95. PubMed ID: 4518586
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia].
    Gepner-Woźniewska M; Retmańska A; Sobczynska-Czechowska Z; Pawelski S
    Acta Haematol Pol; 1973; 4(1):1-9. PubMed ID: 4522083
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy.
    Uzuka Y; Liong SK; Yamagata S
    Tohoku J Exp Med; 1976; 118 Suppl():217-25. PubMed ID: 1067159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 7. Methoxy-9-ellipticine lactate in refractory acute myeloid leukaemia.
    Ansari BM; Thompson EN
    Postgrad Med J; 1975 Feb; 51(592):103-5. PubMed ID: 1054156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W; Resegotti L; Rossi M; Infelise V
    Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia.
    Udén AM; Brenning G; Engstedt L; Franzén S; Gahrton G; Gullbring B; Holm G; Höglund S; Jameson S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skårberg KO; Swedberg B; Wadman B; Wide L
    Scand J Haematol; 1975 Aug; 15(1):72-80. PubMed ID: 1058527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
    Armentrout SA; Burns CP
    Am J Med Sci; 1974 Sep; 268(3):163-8. PubMed ID: 4531223
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.
    Evans DI; Jones PH; Morley CJ
    Cancer; 1975 Nov; 36(5):1547-51. PubMed ID: 1059498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubidomycin in blastic phases of acute promyelocytic and myeloblastic leukemia in children.
    Armata J; Wyszkowski J; Cyklis R
    Acta Paediatr Scand; 1971 Jul; 60(4):471-4. PubMed ID: 5283300
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with the use of cytosine arabinoside in adult acute leukaemia.
    Brodie GN; Penny R
    Med J Aust; 1970 Mar; 1(13):635-7. PubMed ID: 5267173
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged remission maintenance in acute myeloid leukaemia.
    Spiers AS; Goldman JM; Catovsky D; Costello C; Galton DA; Pitcher CS
    Br Med J; 1977 Aug; 2(6086):544-7. PubMed ID: 268229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of acute myeliod leukaemia.
    Friend JH; Giles C; Richardson SG
    J Clin Pathol; 1974 Jan; 27(1):53-4. PubMed ID: 4522738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative observations in the treatment of acute leukaemia.
    Gráf F; Fekete S; Benedek S; Sréter L; Takácsi-Nagy L
    Haematologia (Budap); 1976; 10(1):81-7. PubMed ID: 1070470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High remission-induction rate in acute myeloid leukaemia.
    Gale RP; Cline MJ
    Lancet; 1977 Mar; 1(8010):497-9. PubMed ID: 65605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
    Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K
    Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900
    [No Abstract]   [Full Text] [Related]  

  • 20. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults.
    Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K
    Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.